|
 |
Perspectives on Conjugated Linoleic Acid Research,
Current Status and Future Directions
May 15-16, 2002
Lister Hill Auditorium
Bethesda, MD
Please note that you must have Adobe's free Acrobat
Reader installed on your computer to view any of the files listed on this page. The Adobe Acrobat Reader runs on either Windows PC or Macintosh platforms, and can be downloaded here.
Conference Presentations:
- The Origin of CLA
Dale E. Bauman, Ph.D.
Department of Animal Science, Division of Nutritional Sciences
Cornell University
- Documentation of CLA Intake in Humans; What We Know and What We Should
Know
Shelley McGuire, Ph.D.
Department of Food Science and Human Nutrition
Washington State University
- Concepts for Development of an Anlytical Method to Determine CLA Composition in Food, Dietary Supplements, and Reference Materials
Martin P. Yurawecz, B.A.
U.S. Food and Drug Administration
- Conjugated Linoleic Acid Isomers and
Mammary Lipid Metabolism
Lance H. Baumgard, Ph.D.
Department of Animal Sciences
University of Arizona
- Panel Discussion: Potential Mechanisms for CLA-Mediated
Alteration of Body Composition and Lipid Metabolism
Harry J. Mersmann, Ph.D.
USDA Agricultural Research Service
Children's Nutrition Research Center
Department of Pediatrics
Baylor College of Medicine
- CLA and Mammary Cancer Prevention Research
Clement Ip, Ph.D.
Department of Experimental Pathology
Roswell Park Cancer Institute
- Panel Discussion: Research Needs in CLA and Cancer Prevention
Clement Ip, Ph.D.
Department of Experimental Pathology
Roswell Park Cancer Institute
- CLA in Experimental Atherosclerosis
David Kritchevsky, Ph.D.
The Wistar Institute
- Conjugated Linoleic Acid Reduces Fasting Glucose
and is Inversely Correlated with Serum Leptin in Subjects with Type 2 Diabetes Mellitus
Martha A. Belury, Ph.D., R.D.
Department of Pathobiology
University of Washington
- CLA and Bone Formation
Bruce A. Watkins, Ph.D.
Department of Food Science/Agriculture
Purdue University
- Panel Discussion: Mechanisms of Conjugated Linoleic
Acid in Health and Disease
Josep Bassaganya-Riera, DVM, Ph.D.
Veterinary Medical Research Institute
Iowa State University
- Panel Discussion: CLA for Athlerosclerosis and Diabetes Therapy:
Opportunities, State of the Field and Future Research Directions
Karen L. Houseknecht, Ph.D.
Department of Cardiovascular and Metabolic Diseases
Pfizer Global Research and Development
- Seroprotection: CLA Stimulates Antigen
Specific Antibody Production in Humans
Marianne O'Shea, Ph.D.
Department of Lipid Nutrition
Loders Croklaan
- Panel Discussion: Human Trials / Efficacy
Darshan S. Kelley, Ph.D.
Western Human Nutrition Research Center
Nutrition Department of the University of California
ARS/USDA at the University of California, Davis
|
|
|
|
